Translate Your Research
GENEVA EXPERTISE
Geneva is adept at navigating the intricacies of government acquisitions and the military medical research environment, including negotiating Intellectual Property (IP) terms and Cooperative Research and Development Agreements (CRADAs). Geneva strives to build and accelerate the pathway to commercialization, putting it into the hands of end-users.
Geneva’s experts engage with research teams to develop and implement plans for:
- Product development
- Manufacturing
- Clinical translation
- Regulatory support
- Product launch
- Commercialization strategies
PHASES OF DEVELOPMENT
Geneva quickly enables the rapid introduction of new products based on industry needs and technology solutions for product goals to the marketplace. Geneva has demonstrated past performance in the following areas: Idea Generation, Research & Development, Technology Roadmapping, Proof of Concept Testing, Clinical Translation, Commercialization, and Robust Program Management.
Tech Transfer Case Study
Theradaptive
Geneva has worked with Theradaptive, Inc., a privately-held biotechnology company focused on regenerative medicine technology, on getting their therapeutic platform into the clinic since 2017. The company’s founder is a 20-year Army veteran and MIT alumnus retired LTC Luis Alvarez, PhD. LTC Alvarez developed the platform technology during active duty.
In this Case Study, you will find:
Tech Transfer Case Study
Wearable Life-Support Technology: The CROSS System
Geneva’s dedication to pioneering medical technologies is exemplified by the recent patent issuance of the Combat Resuscitation Organ Support System (CROSS), a wearable life-support vest. Developed by Dr. Andriy Batchinsky and the Autonomous Reanimation and Evacuation (AREVA) Research Program team, CROSS represents a breakthrough in battlefield and civilian trauma care.
This innovative system integrates lung and renal support into a compact, wearable device, providing crucial support where traditional machines cannot reach. Its development underscores Geneva’s role in advancing technologies from concept through to protected intellectual property, enhancing care in critical environments.